Morgan Stanley
KMTS icon

Morgan Stanley’s Kestra Medical Technologies KMTS Stock Holding History

Morgan Stanley’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Sell
53,423
-92,138
-63% -$1.93M ﹤0.01% 5073
2026
Q1 		$2.9M Buy
145,561
+60,109
+70% +$1.42M ﹤0.01% 4493
2025
Q4 		$2.27M Buy
85,452
+41,587
+95% +$1.07M ﹤0.01% 4723
2025
Q3 		$1.04M Buy
43,865
+2,223
+5% +$39.8K ﹤0.01% 5154
2025
Q2 		$690K Buy
41,642
+36,854
+770% +$805K ﹤0.01% 5298
2025
Q1 		$119K Buy
+4,788
New +$110K ﹤0.01% 5935

Other funds holding KMTS

Bain Capital Investors
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Morgan Stanley's KMTS Position: Q2 2026 in Review

Morgan Stanley reduced its Kestra Medical Technologies (KMTS) stake by 63% in Q2 2026, selling an estimated $1.93M and leaving 53,423 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #5073.

Morgan Stanley first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.9M in Q1 2026. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Morgan Stanley held 53,423 shares of Kestra Medical Technologies worth $1.36M as of Q2 2026.
  • Morgan Stanley sold 92,138 Kestra Medical Technologies shares in Q2 2026, an estimated $1.93M.
  • Kestra Medical Technologies made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5073 holding.
  • Morgan Stanley first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • Morgan Stanley's Kestra Medical Technologies position peaked at $2.9M in Q1 2026.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.